DEC orders changes at Great Lakes Cheese after Ischua Creek fish kill
Breaking News
By BOB CLARK bclark@oleantimesherald.com 
August 29, 2025
FRANKLINVILLE — State environmental officers said immediate changes are needed after a fish kill in Ischua Creek was triggered by pollution from the G...
HuidaGene Therapeutics Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Editing HG202 for Macular Degeneration
Hand-out
Press Releases
Huidagene Therapeutics  
November 4, 2024

HuidaGene Therapeutics Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Editing HG202 for Macular Degeneration

HG202 is the first CRISPR/Cas13Y RNA-targeting therapy to enter clinical development and the only clinical-stage CRISPR RNA-editing therapy for age-related macular degenerationPreclinical studies in laser-induced CNV mice showed HG202 reduced

avatar profile Olean Times Herald

Olean Times Herald


Local & Social